1
|
Lehnen NC, Haase R, Schmeel FC, Vatter H, Dorn F, Radbruch A, Paech D. Automated Detection of Cerebral Aneurysms on TOF-MRA Using a Deep Learning Approach: An External Validation Study. AJNR Am J Neuroradiol 2022; 43:1700-1705. [PMID: 36357154 DOI: 10.3174/ajnr.a7695] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2022] [Accepted: 10/05/2022] [Indexed: 11/12/2022]
Abstract
BACKGROUND AND PURPOSE Cerebral aneurysms yield the risk of rupture, severe disability and death. Thus, early detection of cerebral aneurysms is crucial to ensure timely treatment, if necessary. AI-based software tools are expected to enhance radiologists' performance in detecting pathologies like cerebral aneurysms in the future. Our aim was to evaluate the diagnostic performance of an artificial intelligence-based software designed to detect intracranial aneurysms on TOF-MRA. MATERIALS AND METHODS One hundred ninety-one MR imaging data sets were analyzed using the software mdbrain for the presence of intracranial aneurysms on TOF-MRA obtained using two 3T MR imaging scanners or a 1.5T MR imaging scanner according to our clinical standard protocol. The results were compared with the reading of an experienced radiologist as a criterion standard to measure the sensitivity, specificity, positive and negative predictive values, and accuracy of the software. Additionally, detection rates depending on size, morphology, and location of the aneurysms were evaluated. RESULTS Fifty-four aneurysms were detected by the expert reader. The overall sensitivity of the software for the detection of cerebral aneurysms was 72.6%, the specificity was 87.2%, and the accuracy was 82.6%. The positive predictive value was 67.9%, and the negative predictive value was 88.5%. We observed a sensitivity of 100% for saccular aneurysms of >5 mm without signs of thrombosis and low detection rates for fusiform or thrombosed aneurysms of 33.3% and 16.7%, respectively. Of 8 aneurysms that were not included in the initial written reports but were detected by the expert reader, retrospectively, 4 were detected by the software. CONCLUSIONS Our data suggest that the software can assist radiologists in reporting TOF-MRA. The software was highly reliable in detecting saccular aneurysms, while for fusiform or thrombosed aneurysms, further improvements are needed. Further studies are necessary to investigate the impact of the software on detection rates, interrater reliability, and reading times.
Collapse
Affiliation(s)
- N C Lehnen
- From the Departments of Neuroradiology (N.C.L., R.H., F.C.S., F.D., A.R., D.P.)
| | - R Haase
- From the Departments of Neuroradiology (N.C.L., R.H., F.C.S., F.D., A.R., D.P.)
| | - F C Schmeel
- From the Departments of Neuroradiology (N.C.L., R.H., F.C.S., F.D., A.R., D.P.)
| | - H Vatter
- Neurosurgery (H.V.), University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
| | - F Dorn
- From the Departments of Neuroradiology (N.C.L., R.H., F.C.S., F.D., A.R., D.P.)
| | - A Radbruch
- From the Departments of Neuroradiology (N.C.L., R.H., F.C.S., F.D., A.R., D.P.)
| | - D Paech
- From the Departments of Neuroradiology (N.C.L., R.H., F.C.S., F.D., A.R., D.P.)
| |
Collapse
|
2
|
Deike-Hofmann K, von Lampe P, Eerikaeinen M, Ting S, Schlüter S, Schlemmer PH, Bechrakis N, Forsting M, Radbruch A. Enhancement der Vorderen Augenkammer ist ein Prediktor für die Optikusinfiltration bei Retinoblastomen. ROFO-FORTSCHR RONTG 2022. [DOI: 10.1055/s-0042-1749875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
| | | | | | - S Ting
- Pathologie, Uniklinik Essen, Essen
| | | | | | | | | | | |
Collapse
|
3
|
Ostendorf L, Garantziotis P, Wagner DL, Durek P, Heinrich F, Enghard P, Burmester GR, Radbruch A, Mashreghi MF, Hiepe F, Alexander T. POS0010 CD38+ MEMORY T CELLS ARE A FUNCTIONALLY DISTINCT SUBSET THAT IS EXPANDED IN SLE AND ASSOCIATED WITH LUPUS NEPHRITIS. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.3104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:We recently reported the beneficial clinical responses of the anti-CD38 monoclonal antibody daratumumab in two patients with systemic lupus erythematosus (SLE) [1]. While the primary rationale for its use was the depletion of autoantibody-producing long-lived plasma cells, daratumumab may promote additional therapeutic effects on CD38-expressing T cells, but their origin, lifestyle and role in lupus pathophysiology remains elusive.Objectives:To investigate the phenotype, transcriptional program, functional properties and clinical associations of CD4+ and CD8+CD38+ memory T cells in SLE compared to healthy controls (HC).Methods:CD38-expression on memory T cell subsets was measured by flow cytometry in 65 patients with SLE and 28 healthy controls. We investigated the functional capacity of CD38+ T cells using CFSE staining and intracellular cytokine staining after polyclonal stimulation. Additionally, we performed single-cell transcriptome and T-cell-receptor sequencing of 7 SLE patients and 7 matched healthy controls, including surface protein expression analysis using CITE-seq (RNA-barcoded) antibodies.Results:Compared to healthy controls, the frequency of CD38-expressing memory T cells in SLE was significantly increased in both CD4+ and CD8+ T cells. SLE patients with a previous or current lupus nephritis had significantly increased levels of CD8+CD38+ memory T cells compared to those without history of renal involvement. CD38+ memory T cells expressed increased levels of Ki-67 and displayed higher proliferative capacity upon polyclonal stimulation than their CD38- counterparts, both in SLE patients and HC, while they showed decreased ability to secrete IFN-γ, IL-2, GM-CSF and TNF-α. Single-cell transcriptome sequencing revealed that CD8+CD38+ memory T cells were enriched within terminally differentiated, cytotoxic CD8 T cells, and had reduced TCR repertoire diversity compared to their CD38- counterparts. CD8+CD38+ memory T cells from SLE patients had significantly higher expression of type I interferon associated genes, both compared to CD38- memory T cells from SLE patients and CD38+ cells from HCs.Conclusion:CD38+ memory T cells with increased proliferative capacity but altered effector functions are significantly expanded in peripheral blood of SLE and correlate with the lupus nephritis. Although the factors mediating their generation and their precise role in the disease pathophysiology remain to be investigated, CD38-expressing T cells may be useful as a future biomarker for lupus nephritis.References:[1]Ostendorf L, Burns M, Durek P, Heinz GA, Heinrich F, Garantziotis P, et al. Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus. N Engl J Med. 2020 Sep 17;383(12):1149–55.[2]Katsuyama E, Suarez-Fueyo A, Bradley SJ, Mizui M, Marin AV, Mulki L, et al. The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections. Cell Reports. 2020 Jan;30(1):112-123.e4.Acknowledgements:We thank our patients and healthy controls for making our research possible.Disclosure of Interests:None declared.
Collapse
|
4
|
Ostendorf L, Schneider U, Urbicht M, Enghard P, Heinrich F, Durek P, Heinz G, Mei H, Mashreghi MF, Burmester GR, Radbruch A, Hiepe F, Alexander T. AB0385 TARGETING CD38 IN SYSTEMIC LUPUS ERYTHEMATOSUS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.5052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Depletion of long-lived plasma cells (PC) resembles a novel concept for the treatment of antibody-mediated autoimmune diseases, such as systemic lupus erythematosus (SLE). Therapeutic approaches such as autologuos stem-stem cell transplantation and proteasome inhibition are limited by significant treatment-related toxicity. A novel target for PC depletion is CD38, a surface protein that is highly expressed on plasma cells (PCs) but also activated T-cells and most myeloid cells. Daratumumab is a monoclonal antibody targeting CD38 that is licensed for the treatment of multiple myeloma.Objectives:Here, we aimed to ascertain clinical safety and efficacy of Daratumumab for the treatment of refractory SLE, as well as to gain insights into effects of Daratumumab on the immune system.Methods:We treated two SLE patients with life- and organ-threatening SLE with four weekly dosis of 16 mg/kg Daratumumab. We performed integrative analyses of clinical, serological and immunological effects over a follow-up period of 6 months. Using flow cytometry and single-cell RNA and T-cell receptor sequencing we followed CD38 expression and composition of peripheral blood leukocytes with a special focus on memory T cells.Results:Patient 1, a 50-year old woman, suffered from active biopsy-proven class III lupus nephritis (LN) with nephrotic syndrome, pericarditis, arthritis and skin rash. Upon Daratumumab treatment, her glomerular filtration rate normalized within 3 months and proteinuria gradually declined from 6.4 to 1.9g/g Creatinine during the 180-day follow-up period. Pericarditis, arthritis and skin rash completely resolved. Patient 2, a 32-year-old woman, presented with autoimmune hemolytic anemia requiring blood transfusions, immune thrombocytopenia and cutaneous vasculitis. Her direct antiglobulin test normalized within 3 months and remained negative throughout follow-up with consecutive recovery of the hemolytic anemia. Immune thrombocytopenia stabilized and vasculitic skin lesions completely resolved. Infusions were well tolerated without severe adverse drug reactions. NK cells and Dendritic Cells were transiently depleted, while numbers of T cells, B cells and Monocytes in the peripheral blood remained stable. CD38+ memory T cells that were expanded prior to treatment were virtually undetectable early after treatment. Their single cell transcriptomics demonstrated an upregulation of genes associated with activation, cytotoxicity and type 1 interferon response. CD38+ CD8+ memory T-cells showed marked oligoclonality. These prominent clones persisted upon treatment but their transcription profile gradually normalized.Conclusion:Daratumumab appears to be a safe and effective treatment for refractory SLE. Further investigations are warranted to establish the efficacy in a clinical trial and to gain further insights into the pathophysiologic mechanism of action.Disclosure of Interests:Lennard Ostendorf: None declared, Udo Schneider: None declared, Marie Urbicht: None declared, Philipp Enghard: None declared, Frederik Heinrich: None declared, Pawel Durek: None declared, Gitta Heinz: None declared, Henrik Mei: None declared, Mir-Farzin Mashreghi: None declared, Gerd Rüdiger Burmester Consultant of: AbbVie Inc, Eli Lilly, Gilead, Janssen, Merck, Roche, Pfizer, and UCB Pharma, Speakers bureau: AbbVie Inc, Eli Lilly, Gilead, Janssen, Merck, Roche, Pfizer, and UCB Pharma, Andreas Radbruch: None declared, Falk Hiepe: None declared, Tobias Alexander: None declared
Collapse
|
5
|
Ostendorf L, Enghard P, Durek P, Heinrich F, Mashreghi MF, Burmester GR, Radbruch A, Hiepe F, Alexander T. AB0138 INCREASED CD38 EXPRESSION LEVELS ON IMMUNE CELL SUBSETS IN SYSTEMIC LUPUS ERYTHEMATOSUS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.6531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Plasma Cells (PCs) are implicated in the pathogenesis of Systemic Lupus erythematosus (SLE) and their targeting proved a promising treatment modality. As there is a monoclonal therapeutic antibody targeting CD38 licensed for clinical use in multiple myeloma, plasma cell depletion via CD38 seems to represent a promising path in SLE treatment. While CD38 Is highly expressed on plasmacells, it is present on the surface of subsets of T and B lymphocytes as well as myeloid cells.Objectives:Here we aim to identify the differential expression of CD38 on peripheral blood leukocytes in SLE compared to healthy controls (HC) investigate the function of CD38+ T lymphocytesMethods:We performed flow cytometry to investigate the expression of CD38 on peripheral blood mononuclear cells of SLE patients (n=36) and HCs (n=20). We additionally analyzed the expression of T lymphocytes within the urine of patients with lupus nephritis as well as the skin of SLE patients. We investigated the inflammatory potential of CD38 positive memory T lymphocytes after stimulation and performed single-cell RNA sequencing analyses.Results:CD38 Expression is increased on certain immune cell subsets: Plasmablasts and unswitched Memory B cells, as well as plasmacytoid dendritic cells and CD16+ non-classical monocytes. We observed a drastic increase CD38 in both memory CD4 and CD8 T lymphocytes in SLE patients. These cells were mostly effector T cells (and not regulatory T cells) and expressed other markers of T cell activation and proliferation. We found an enrichment of CD38+ memory T cells in the urine of patients with lupus nephritis. After polyclonal stimulation of T cells, CD38+ produced less inflammatory cytokines. Preliminary single-cell sequencing results indicate that CD38+ CD8+ T-lymphocytes have decreased clonal diversity and that these cells express genes associated with exhaustion and type 1 interferon response.Conclusion:Increased CD38 expression on various lymphocyte subsets provides an additional rationale for investigating CD38-directed therapies in SLE. Targeting CD38 could not only deplete plasma cells but also has the potential to target interferon alpha producing plasmacytoid dendritic cells and modulate inflammatory T cell functions.Disclosure of Interests:Lennard Ostendorf: None declared, Philipp Enghard: None declared, Pawel Durek: None declared, Frederik Heinrich: None declared, Mir-Farzin Mashreghi: None declared, Gerd Rüdiger Burmester Consultant of: AbbVie Inc, Eli Lilly, Gilead, Janssen, Merck, Roche, Pfizer, and UCB Pharma, Speakers bureau: AbbVie Inc, Eli Lilly, Gilead, Janssen, Merck, Roche, Pfizer, and UCB Pharma, Andreas Radbruch: None declared, Falk Hiepe: None declared, Tobias Alexander: None declared
Collapse
|
6
|
Goebel J, Gaida BJ, Wanke I, Kleinschnitz C, Koehrmann M, Forsting M, Moenninghoff C, Radbruch A, Junker A. Is Histologic Thrombus Composition in Acute Stroke Linked to Stroke Etiology or to Interventional Parameters? AJNR Am J Neuroradiol 2020; 41:650-657. [PMID: 32193192 DOI: 10.3174/ajnr.a6467] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2019] [Accepted: 01/24/2020] [Indexed: 12/24/2022]
Abstract
BACKGROUND AND PURPOSE Detailed insight into the composition of thrombi retrieved from patients with ischemic stroke by mechanical thrombectomy might improve pathophysiologic understanding and therapy. Thus, this study searched for links between histologic thrombus composition and stroke subtypes and mechanical thrombectomy results. MATERIALS AND METHODS Thrombi from 85 patients who had undergone mechanical thrombectomy for acute ischemic stroke between December 2016 and March 2018 were studied retrospectively. Thrombi were examined histologically. Preinterventional imaging features, stroke subtypes, and interventional parameters were re-analyzed. Statistical analysis was performed with the Kruskal-Wallis test, Mann-Whitney U test, or Spearman correlation as appropriate. RESULTS Cardioembolic thrombi had a higher percentage of macrophages and a tendency toward more platelets than thrombi of large-artery atherosclerotic stenosis (P = .021 and .003) or the embolic stroke of undetermined source (P = .037 and .099) subtype. Thrombi prone to fragmentation required the combined use of contact aspiration and stent retrieval (P = .021) and were associated with an increased number of retrieving maneuvers (P = .001), longer procedural times (P = .001), and a higher lymphocyte content (P = .035). CONCLUSIONS We interpreted the higher macrophage and platelet content in cardioembolic thrombi compared with large-artery atherosclerotic stenosis or embolic stroke of undetermined source thrombi as an indication that the latter type might be derived from an atherosclerotic plaque rather than from an undetermined cardiac source. The extent of thrombus fragmentation was associated with a more challenging mechanical thrombectomy and a higher lymphocyte content of the thrombi. Thus, thrombus fragmentation not only might be caused by the recanalization procedure but also might be a feature of a lymphocyte-rich, difficult-to-retrieve subgroup of thrombi.
Collapse
Affiliation(s)
- J Goebel
- From the Departments of Diagnostic and Interventional Radiology and Neuroradiology (J.G., I.W., M.F., C.M., A.R.)
| | - B-J Gaida
- Neuroradiological Centre (B.-J.G.), Clinic Hirslanden, Zurich, Switzerland
| | - I Wanke
- From the Departments of Diagnostic and Interventional Radiology and Neuroradiology (J.G., I.W., M.F., C.M., A.R.)
| | - C Kleinschnitz
- Clinic of Neurology (C.K., M.K.), University Hospital Essen, Essen, Germany
| | - M Koehrmann
- Clinic of Neurology (C.K., M.K.), University Hospital Essen, Essen, Germany
| | - M Forsting
- From the Departments of Diagnostic and Interventional Radiology and Neuroradiology (J.G., I.W., M.F., C.M., A.R.)
| | - C Moenninghoff
- From the Departments of Diagnostic and Interventional Radiology and Neuroradiology (J.G., I.W., M.F., C.M., A.R.)
| | - A Radbruch
- From the Departments of Diagnostic and Interventional Radiology and Neuroradiology (J.G., I.W., M.F., C.M., A.R.)
| | | |
Collapse
|
7
|
Oldenburg D, Guberina N, Stolte B, Kizina K, Stenzel E, Radbruch A, Kleinschnitz C, Hagenacker T, Forsting M, Mönninghoff C. Radiation exposure of image-guided intrathecal administration of nusinersen to adult patients with spinal muscular atrophy. Neuroradiology 2019; 61:565-574. [PMID: 30868184 DOI: 10.1007/s00234-019-02189-x] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2018] [Accepted: 02/18/2019] [Indexed: 02/06/2023]
Abstract
PURPOSE To examine diagnostic reference levels (DRL) and achievable doses (AD) of image-guided and size-specific dose estimates (SSDE) and organ and effective doses of CT-guided intrathecal nusinersen administration to adult patients with spinal muscular atrophy (SMA). METHODS This study involved a total of 60 image-guided intrathecal nusinersen treatments between August 2017 and June 2018. Patient cohort comprised 14 adult patients with the following SMA types: type 2 (n = 9) and type 3 (n = 5) with a mean age of 33.6 years (age range 25-57 years). DRL, AD, SSDE, organ, and effective doses were assessed with a dose-monitoring program based on the Monte Carlo simulation techniques. RESULTS DRL and AD for computed tomography are summarised as follows: in terms of CT-dose index (CTDIvol), DRL 56.4 mGy and AD 36.7 mGy; in terms of dose-length product (DLP), DRL 233.1 mGy cm and AD 120.1 mGy cm. DRL and AD for fluoroscopic guidance were distributed as follows: in terms of dose-area product (DAP), DRL 239.1 μGy m2 and AD 135.2 mGy cm2. Mean SSDE was 9.2 mGy. Mean effective dose of the CT-guided injections was 2.5 mSv (median 2.0 mSv, IQR 1.3-3.2 mSv). Highest organ doses in the primary beam of radiation were the small intestine 12.9 mSv, large intestine 9.5 mSv, and ovaries 3.6 mSv. CONCLUSION Radiation exposure of SMA patients measured as DRLs is generally not higher compared with patients without SMA despite severe anatomical hazards. Dose monitoring data may allow clinicians to stratify radiation risk, identify organs at risk, and adopt measures for specific radiation dose reduction.
Collapse
Affiliation(s)
- D Oldenburg
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.
| | - N Guberina
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany
| | - B Stolte
- Department of Neurology, University Hospital Essen, Essen, Germany
| | - K Kizina
- Department of Neurology, University Hospital Essen, Essen, Germany
| | - E Stenzel
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany
| | - A Radbruch
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany
| | - C Kleinschnitz
- Department of Neurology, University Hospital Essen, Essen, Germany
| | - T Hagenacker
- Department of Neurology, University Hospital Essen, Essen, Germany
| | - M Forsting
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany
| | - C Mönninghoff
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany
| |
Collapse
|
8
|
Guberina N, Dietrich U, Radbruch A, Goebel J, Deuschl C, Ringelstein A, Köhrmann M, Kleinschnitz C, Forsting M, Mönninghoff C. Detection of early infarction signs with machine learning-based diagnosis by means of the Alberta Stroke Program Early CT score (ASPECTS) in the clinical routine. Neuroradiology 2018; 60:889-901. [PMID: 30066278 DOI: 10.1007/s00234-018-2066-5] [Citation(s) in RCA: 54] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2018] [Accepted: 07/20/2018] [Indexed: 11/30/2022]
Abstract
PURPOSE New software solutions emerged to support radiologists in image interpretation in acute ischemic stroke. This study aimed to validate the performance of computer-aided assessment of the Alberta Stroke Program Early CT score (ASPECTS) for detecting signs of early infarction. METHODS ASPECT scores were assessed in 119 CT scans of patients with acute middle cerebral artery ischemia. Patient collective was differentiated according to (I) normal brain, (II) leukoencephalopathic changes, (III) infarcts, and (IV) atypical parenchymal defects (multiple sclerosis, etc.). ASPECTS assessments were automatically provided by the software package e-ASPECTS (Brainomix®, UK) (A). Subsequently, three neuroradiologists (B), (C), and (D) examined independently 2380 brain regions. Interrater comparison was performed with the definite infarct core as reference standard after best medical care (thrombolysis and/or thrombectomy). RESULTS Interrater comparison revealed higher correlation coefficient of (B) 0.71, (C) 0.76, and of (D) 0.80 with definite infarct core compared to (A) 0.59 for ASPECTS assessment in the acute ischemic stroke setting. While (B), (C), and (D) showed a significant correlation for individual patient groups (I), (II), (III), and (IV), except for (D) (II), (A) was not significant in patient groups with pre-existing changes (II), (III), and (IV). The following sensitivities, specificities, PPV, NPV, and accuracies given in percent were achieved: (A) 83, 57, 55, 82, and 67; (B) 74, 76, 69, 83, and 77; (C) 80.8, 85.2, 76, 84, and 80; (D) 63, 90.7, 82, 79, and 80, respectively. CONCLUSION For ASPECTS assessment, the examined software may provide valid data in case of normal brain. It may enhance the work of neuroradiologists in clinical decision making. A final human check for plausibility is needed, particularly in patient groups with pre-existing cerebral changes.
Collapse
Affiliation(s)
- Nika Guberina
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.
| | - U Dietrich
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany
| | - A Radbruch
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany
| | - J Goebel
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany
| | - C Deuschl
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany
| | - A Ringelstein
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.,Department of Radiology and Neuroradiology, Mariahilf Mönchengladbach, Mönchengladbach, Germany
| | - M Köhrmann
- Clinic for Neurology, University Hospital Essen, Essen, Germany
| | - C Kleinschnitz
- Clinic for Neurology, University Hospital Essen, Essen, Germany
| | - M Forsting
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany
| | - C Mönninghoff
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany
| |
Collapse
|
9
|
Schett G, Bozec A, Bekeredjian-Ding I, Chang HD, David JP, Dörner T, Grässel S, Gunzer M, Manz R, Mei H, Mielenz D, Müller-Ladner U, Neumann E, Radbruch A, Richter W, Straub RH. [New insights into the function of bone marrow]. Z Rheumatol 2018; 77:4-7. [PMID: 29691692 DOI: 10.1007/s00393-018-0456-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Affiliation(s)
- G Schett
- Universitätsklinikum Erlangen, Medizinische Klinik 3 - Rheumatologie und Immunologie, Friedrich-Alexander Universität Erlangen - Nürnberg, Ulmenweg 18, 91054, Erlangen, Deutschland.
| | - A Bozec
- Universitätsklinikum Erlangen, Medizinische Klinik 3 - Rheumatologie und Immunologie, Friedrich-Alexander Universität Erlangen - Nürnberg, Ulmenweg 18, 91054, Erlangen, Deutschland
| | - I Bekeredjian-Ding
- Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen, Deutschland
| | - H-D Chang
- Deutsches Rheuma-Forschungszentrum Berlin (DRFZ), Leibniz Gemeinschaft, Charitéplatz 1, 10117, Berlin, Deutschland
| | - J-P David
- Institut für Osteologie und Biomechanik, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland
| | - T Dörner
- Med. Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland
| | - S Grässel
- Orthopädische Klinik, Exp. Orthopädie, Universität Regensburg, ZMB im Biopark 1, 93053, Regensburg, Deutschland
| | - M Gunzer
- Universitätsklinikum Essen, Institut für Experimentelle Immunologie und Bildgebung, Universität Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Deutschland
| | - R Manz
- Institut für Systemische Entzündungsforschung, Universität Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland
| | - H Mei
- Deutsches Rheuma-Forschungszentrum Berlin (DRFZ), Leibniz Gemeinschaft, Charitéplatz 1, 10117, Berlin, Deutschland
| | - D Mielenz
- Molekular-Immunologische Abteilung in der Medizinischen Klinik 3, Universitätsklinikum Erlangen, Glückstr. 6, 91054, Erlangen, Deutschland
| | - U Müller-Ladner
- Abt. Rheumatologie und Klinische Immunologie, Justus-Liebig-Universität Gießen, Campus Kerckhoff, Benekestr. 2, 61231, Bad Nauheim, Deutschland
| | - E Neumann
- Abt. Rheumatologie und Klinische Immunologie, Justus-Liebig-Universität Gießen, Campus Kerckhoff, Benekestr. 2, 61231, Bad Nauheim, Deutschland
| | - A Radbruch
- Deutsches Rheuma-Forschungszentrum Berlin (DRFZ), Leibniz Gemeinschaft, Charitéplatz 1, 10117, Berlin, Deutschland
| | - W Richter
- Forschungszentrum für Experimentelle Orthopädie, Universitätsklinikum Heidelberg, Schlierbacher Landstr. 200a, 69118, Heidelberg, Deutschland
| | - R H Straub
- Labor für Exp. Rheumatologie und Neuroendokrinimmunologie, Klinik für Innere Medizin, Universitätsklinikum, 93053, Regensburg, Deutschland
| |
Collapse
|
10
|
Schaible HG, Chang HD, Grässel S, Haibel H, Hess A, Kamradt T, Radbruch A, Schett G, Stein C, Straub RH. [Research consortium Neuroimmunology and pain in the research network musculoskeletal diseases]. Z Rheumatol 2018; 77:24-30. [PMID: 29654392 DOI: 10.1007/s00393-018-0459-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
BACKGROUND The research consortium Neuroimmunology and Pain (Neuroimpa) explores the importance of the relationships between the immune system and the nervous system in musculoskeletal diseases for the generation of pain and for the course of fracture healing and arthritis. MATERIAL AND METHODS The spectrum of methods includes analyses at the single cell level, in vivo models of arthritis and fracture healing, imaging studies on brain function in animals and humans and analysis of data from patients. RESULTS Proinflammatory cytokines significantly contribute to the generation of joint pain through neuronal cytokine receptors. Immune cells release opioid peptides which activate opioid receptors at peripheral nociceptors and thereby evoke hypoalgesia. The formation of new bone after fractures is significantly supported by the nervous system. The sympathetic nervous system promotes the development of immune-mediated arthritis. The studies show a significant analgesic potential of the neutralization of proinflammatory cytokines and of opioids which selectively inhibit peripheral neurons. Furthermore, they show that the modulation of neuronal mechanisms can beneficially influence the course of musculoskeletal diseases. DISCUSSION Interventions in the interactions between the immune system and the nervous system hold a great therapeutic potential for the treatment of musculoskeletal diseases and pain.
Collapse
Affiliation(s)
- H-G Schaible
- Institut für Physiologie 1/Neurophysiologie, Universitätsklinikum Jena, Friedrich Schiller Universität Jena, Teichgraben 8, 07743, Jena, Deutschland.
| | - H-D Chang
- Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, Deutschland
| | - S Grässel
- Klinik und Poliklinik für Orthopädie, Experimentelle Orthopädie, Universitätsklinikum Regensburg, Regensburg, Deutschland
| | - H Haibel
- Abteilung für Rheumatologie, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Deutschland
| | - A Hess
- Institut für Pharmakologie, Universitätsklinikum Erlangen-Nürnberg, Erlangen, Deutschland
| | - T Kamradt
- Institut für Immunologie, Universitätsklinikum Jena, Friedrich Schiller Universität Jena, Jena, Deutschland
| | - A Radbruch
- Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, Deutschland
| | - G Schett
- Klinik für Innere Medizin, Universitätsklinikum Erlangen-Nürnberg, Erlangen, Deutschland
| | - C Stein
- Klinik für Anästhesie, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Deutschland
| | - R H Straub
- Klinik für Innere Medizin 1, Universitätsklinikum Regensburg, Regensburg, Deutschland
| |
Collapse
|
11
|
Deuschl C, Kirchner J, Poeppel TD, Schaarschmidt B, Kebir S, El Hindy N, Hense J, Quick HH, Glas M, Herrmann K, Umutlu L, Moenninghoff C, Radbruch A, Forsting M, Schlamann M. 11C-MET PET/MRI for detection of recurrent glioma. Eur J Nucl Med Mol Imaging 2017; 45:593-601. [PMID: 29282517 DOI: 10.1007/s00259-017-3916-9] [Citation(s) in RCA: 54] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2017] [Accepted: 12/11/2017] [Indexed: 11/25/2022]
Abstract
INTRODUCTION Radiological assessment of brain tumors is widely based on the Radiology Assessment of Neuro-Oncology (RANO) criteria that consider non-specific T1 and T2 weighted images. Limitation of the RANO criteria is that they do not include metabolic imaging techniques that have been reported to be helpful to differentiate treatment related changes from true tumor progression. In the current study, we assessed if the combined use of MRI and PET with hybrid 11C-MET PET/MRI can improve diagnostic accuracy and diagnostic confidence of the readers to differentiate treatment related changes from true progression in recurrent glioma. METHODS Fifty consecutive patients with histopathologically proven glioma were prospectively enrolled for a hybrid 11C-MET PET/MRI to differentiate recurrent glioma from treatment induced changes. Sole MRI data were analyzed based on RANO. Sole PET data and in a third evaluation hybrid 11C-MET-PET/MRI data were assessed for metabolic respectively metabolic and morphologic glioma recurrence. Diagnostic performance and diagnostic confidence of the reader were calculated for the different modalities, and the McNemar test and Mann-Whitney U Test were applied for statistical analysis. RESULTS Hybrid 11C-MET PET/MRI was successfully performed in all 50 patients. Glioma recurrence was diagnosed in 35 of the 50 patients (70%). Sensitivity and specificity were calculated for MRI (86.11% and 71.43%), for 11C-MET PET (96.77% and 73.68%), and for hybrid 11C-MET-PET/MRI (97.14% and 93.33%). For diagnostic accuracy hybrid 11C-MET-PET/MRI (96%) showed significantly higher values than MRI alone (82%), whereas no significant difference was found for 11C-MET PET (88%). Furthermore, by rating on a five-point Likert scale significantly higher scores were found for diagnostic confidence when comparing 11C-MET PET/MRI (4.26 ± 0,777) to either PET alone (3.44 ± 0.705) or MRI alone (3.56 ± 0.733). CONCLUSION This feasibility study showed that hybrid PET/MRI might strengthen RANO classification by adding metabolic information to conventional MRI information. Future studies should evaluate the clinical utility of the combined use of 11C-MET PET/MRI in larger patient cohorts.
Collapse
Affiliation(s)
- C Deuschl
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
- Erwin L. Hahn Institute for Magnetic Resonance Imaging, University of Duisburg-Essen, Essen, Germany.
| | - J Kirchner
- Department of Diagnostic and Interventional Radiology, Medical Faculty, University Duesseldorf, Duesseldorf, Germany
| | - T D Poeppel
- Clinic for Nuclear Medicine, University Hospital Essen, Essen, Germany
| | - B Schaarschmidt
- Department of Diagnostic and Interventional Radiology, Medical Faculty, University Duesseldorf, Duesseldorf, Germany
| | - S Kebir
- Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, Essen, Germany
| | - N El Hindy
- Department of Neurosurgery, University Hospital Essen, Essen, Germany
| | - J Hense
- Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany
| | - H H Quick
- Erwin L. Hahn Institute for Magnetic Resonance Imaging, University of Duisburg-Essen, Essen, Germany
- High Field and Hybrid MR Imaging, University Hospital Essen, Essen, Germany
| | - M Glas
- Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, Essen, Germany
| | - K Herrmann
- Clinic for Nuclear Medicine, University Hospital Essen, Essen, Germany
| | - L Umutlu
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
| | - C Moenninghoff
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
| | - A Radbruch
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
| | - M Forsting
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
| | - M Schlamann
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
- Department of Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Germany
| |
Collapse
|
12
|
Haase R, Kieslich P, Weberling L, Kickingereder P, Wick W, Schlemmer H, Bendszus M, Radbruch A. No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after more than 20 Serial Injections of Macrocyclic Gadolinium-Based Contrast Agents. ROFO-FORTSCHR RONTG 2017. [DOI: 10.1055/s-0037-1600321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- R Haase
- Deutsches Krebsforschungszentrum, Radiologie, Heidelberg
| | - P Kieslich
- Universität Mannheim, Psychologie, Mannheim
| | - L Weberling
- Universitätsklinikum Heidelberg, Neuroradiologie, Heidelberg
| | - P Kickingereder
- Universitätsklinikum Heidelberg, Neuroradiologie, Heidelberg
| | - W Wick
- Universitätsklinikum Heidelberg, Neurologie, Heidelberg
| | - H Schlemmer
- Deutsches Krebsforschungszentrum (DKFZ), Radiologie, Heidelberg
| | - M Bendszus
- Universitätsklinikum Heidelberg, Neuroradiologie, Heidelberg
| | - A Radbruch
- Universitätsklinikum Heidelberg, Neuroradiologie, Heidelberg
| |
Collapse
|
13
|
Zimmermann J, Kühl AA, Weber M, Grün JR, Löffler J, Haftmann C, Riedel R, Maschmeyer P, Lehmann K, Westendorf K, Mashreghi MF, Löhning M, Mack M, Radbruch A, Chang HD. T-bet expression by Th cells promotes type 1 inflammation but is dispensable for colitis. Mucosal Immunol 2016; 9:1487-1499. [PMID: 26883725 DOI: 10.1038/mi.2016.5] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2015] [Accepted: 01/03/2016] [Indexed: 02/04/2023]
Abstract
The transcription factor T-bet is highly expressed by Th cells isolated from the inflamed intestine of Crohn's disease patients, and has been regarded a critical driver of murine T cell-induced colitis. However, we show here that T-bet expression by Th cells is not required for the manifestation of T-cell-induced colitis in the presence of segmented filamentous bacteria and Helicobacter hepaticus. T-bet expression by Th cells controls their survival and localization, their repertoire of chemokine and chemokine receptor expression, the accumulation of monocytes and macrophages in the inflamed colon, and their differentiation to the M1 type, i.e., type 1 inflammation. Nevertheless, T-bet-deficient Th cells efficiently induce colitis, as reflected by weight loss, diarrhea, and colon histopathology. T-bet-deficient Th cells differentiate into Th1/17 cells, able to express IFN-γ and IL-17A upon restimulation. While neutralization of IL-17A exacerbated colitis induced by wild-type or T-bet-deficient Th cells, neutralization of IFN-γ completely abolished colitis.
Collapse
Affiliation(s)
- J Zimmermann
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| | - A A Kühl
- Charité Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany
| | - M Weber
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| | - J R Grün
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| | - J Löffler
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| | - C Haftmann
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| | - R Riedel
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| | - P Maschmeyer
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| | - K Lehmann
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| | - K Westendorf
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| | - M-F Mashreghi
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| | - M Löhning
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| | - M Mack
- Universitätsklinikum Regensburg, Regensburg, Germany
| | - A Radbruch
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| | - H D Chang
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), an Institute of the Leibniz Association, Berlin, Germany
| |
Collapse
|
14
|
Kickingereder P, Götz M, Wick A, Neuberger U, Schlemmer H, Radbruch A, Wick W, Bendszus M, Maier-Hein K, Bonekamp D. OS4.6 Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response. Neuro Oncol 2016. [DOI: 10.1093/neuonc/now188.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
15
|
Massenkeil G, Alexander T, Rosen O, Dörken B, Burmester G, Radbruch A, Hiepe F, Arnold R. Long-term follow-up of fertility and pregnancy in autoimmune diseases after autologous haematopoietic stem cell transplantation. Rheumatol Int 2016; 36:1563-1568. [PMID: 27522225 DOI: 10.1007/s00296-016-3531-2] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2016] [Accepted: 07/08/2016] [Indexed: 12/29/2022]
Abstract
Issues of fertility and pregnancy require special attention in the long-term care of patients with autoimmune diseases (AD), who are candidates for haematopoietic stem cell transplantation (HSCT). In this single-centre observational study, we report fertility status and pregnancy outcomes in 15 patients (11 female and 4 male) after immunoablation with cyclophosphamide, antithymocyte globulin and autologous CD34+-selected HSCT for severe, refractory AD. The median follow-up after HSCT was 12 years (range 2-16 years). Impaired fertility was observed in six patients (five females and one male) before HSCT based on sexual hormone measurements. Higher age and cumulative cyclophosphamide dosage before HSCT correlated with fertility impairment. Median serum level of follicle-stimulating hormone (FSH) was significantly higher in female patients at 1 year after HSCT compared to baseline values, but premature ovarian failure developed in only one patient. Four women had five pregnancies and six healthy offsprings during follow-up, and no miscarriages were observed. The mothers were in treatment-free remissions during conception. No peripartal flare of their AD occurred. Although AD patients undergoing HSCT are at risk of developing infertility, pre-HSCT treatment and patients' age seem to have higher impact on long-term fertility status than HSCT itself. HSCT offers the opportunity to conceive during treatment-free remissions with favourable pregnancy outcomes.
Collapse
Affiliation(s)
- G Massenkeil
- Department of Haematology and Oncology, Charité University Medicine, Berlin, Germany. .,Department of Internal Medicine, Klinikum Guetersloh, Reckenberger Strasse 19, 33332, Guetersloh, Germany.
| | - T Alexander
- Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany
| | - O Rosen
- Department of Haematology and Oncology, Charité University Medicine, Berlin, Germany
| | - B Dörken
- Department of Haematology and Oncology, Charité University Medicine, Berlin, Germany
| | - G Burmester
- Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany
| | - A Radbruch
- German Rheumatism Research Centre, Berlin, Germany
| | - F Hiepe
- Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany
| | - R Arnold
- Department of Haematology and Oncology, Charité University Medicine, Berlin, Germany
| |
Collapse
|
16
|
Radbruch A. SP0064 Pathogenic Memory Plasma Cells in Rheumatic Diseases - A Critical Target of Therapy. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.6308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
17
|
Kickingereder P, Kickingereder P, Götz M, Muschelli J, Wick A, Neuberger U, Shinohara R, Radbruch A, Schlemmer H, Wick W, Bendszus M, Maier-Hein K, Bonekamp D. Large-scale radiomic profiling of glioblastoma identifies an imaging signature for predicting and stratifying antiangiogenic treatment response. ROFO-FORTSCHR RONTG 2016. [DOI: 10.1055/s-0036-1581194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
18
|
Paech D, Zaiss M, Windschuh J, Görke S, Milde K, Meissner J, Burth S, Kickingereder P, Wick W, Ladd M, Bachert P, Bendszus M, Schlemmer H, Radbruch A. Quantitative CEST-Bildgebung bei Glioblastompatienten am 7 Tesla Ultrahochfeldtomografen. ROFO-FORTSCHR RONTG 2016. [DOI: 10.1055/s-0036-1581653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
19
|
Weberling L, Kieslich P, Schlemmer H, Bendszus M, Radbruch A. Keine Steigerung der Signalintensität des Nucleus Dentatus und Globus Pallidus im nativen T1-gewichteten Bild nach serieller Gabe des makrozyklischen Kontrastmittels Gadobutrol. ROFO-FORTSCHR RONTG 2016. [DOI: 10.1055/s-0036-1581573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
20
|
Kickingereder P, Kickingereder P, Sahm F, Radbruch A, Wick W, Heiland S, Deimling AV, Bendszus M, Wiestler B. Radiogenomic rCBV-imaging visualizes the moleculare signature of IDH-mutant and wildtype gliomas. ROFO-FORTSCHR RONTG 2016. [DOI: 10.1055/s-0036-1581722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
21
|
Kickingereder P, Kickingereder P, Radbruch A, Burth S, Wick A, Heiland S, Schlemmer H, Wick W, Bendszus M, Bonekamp D. MR-perfusion derived hemodynamic parametric response mapping of bevacizumab efficacy in recurrent glioblastoma. ROFO-FORTSCHR RONTG 2016. [DOI: 10.1055/s-0036-1581724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
22
|
Radbruch A. Retention von MR-Kontrastmitteln: War NSF nur der Anfang? Was wissen wir heute? ROFO-FORTSCHR RONTG 2016. [DOI: 10.1055/s-0036-1581571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
23
|
Serra A, El Khassawna T, Petersen A, Schlundt C, Könnecke I, Schell H, Volk HD, Radbruch A, Schmidt-Bleek K, Duda G. A4.01 T cells are critical regulators of soft callus mineralization and normal deposition of collagen I during bone repair. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-209124.89] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
24
|
Schulte-Wrede U, Sörensen T, Grün JR, Syrbe U, Sieper J, Häupl T, Radbruch A, Grützkau A. A6.09 Nk cells as biosensors for responsiveness to etanercept in ankylosing spondylitis (Morbus Bechterew). Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-209124.121] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
25
|
Baumgart S, Bertolo M, Glatzel V, Peddinghaus A, Enghard P, Radbruch A, Hiepe F, Grützkau A. A6.10 A biomarker discovery approach for urinary cells in lupus nephritis. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-209124.122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
26
|
Smiljanovic B, Stuhlmüller B, Sörensen T, Bonin M, Pade S, Backhaus B, Maslinski W, Burmester GR, Radbruch A, Grützkau A, Häupl T. A6.07 Tissue- and cell-specific transcriptomes indicate systemic nature of ra and revealed combinations of protein biomarkers relevant for disease characterisation in serum. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-209124.119] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
27
|
Humrich JY, von Spee-Mayer C, Siegert E, Bertolo M, Abdirama D, Rose A, Enghard P, Radbruch A, Burmester GR, Riemekasten G. A7.06 Low-dose IL-2 therapy in refractory sle: Insights from a phase I/IIA clinical trial. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-209124.137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
28
|
Maschmeyer P, Zimmermann J, Tran CL, Haftmann C, Rausch B, Riedel R, Herzog S, Chang HD, Radbruch A, Mashreghi MF. A7.19 Systemic inhibition of MIR-148A by antagomirs reduces CD4 +T helper cell numbers and alleviates inflammation in a preclinical model of transfer colitis. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-209124.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
29
|
Bardua M, Haftmann C, Fang Z, Buttgereit A, Mcgrath M, Westendorf K, Maschmeyer P, Radbruch H, Chang HD, Rajewsky N, Radbruch A, Mashreghi MF. A2.22 Microrna-31 modulates the expression of mobility related genes and the motility of T helper 1 lymphocytes. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-209124.57] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
30
|
Abdirama D, Enghard P, Tesch S, Radbruch A, Burmester GR, Riemekasten G. A2.17 Detection of autoantigen-specific CD4 +T cells associated with systemic lupus erythematosus. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-209124.52] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
31
|
Latsoudis H, Mashreghi MF, Gruen J, Chang HD, Stuhlmueller B, Repa A, Gergiannaki I, Kabouraki E, Papakosta P, Haeupl T, Radbruch A, Sidiropoulos P, Kardassis D, Boumpas D, Goulielmos G. Differential expression of miR-4520a is associated with gain of function mutations in Familial Mediterranean Fever (FMF). Pediatr Rheumatol Online J 2015. [PMCID: PMC4597287 DOI: 10.1186/1546-0096-13-s1-o10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
|
32
|
Radbruch A. [Not Available]. Drug Res (Stuttg) 2015; 65 Suppl 1:S16-7. [PMID: 26536180 DOI: 10.1055/s-0035-1558065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- A Radbruch
- Deutsches RheumaForschungsZentrum Berlin, ein Leibniz Institut
| |
Collapse
|
33
|
Affiliation(s)
- J Dong
- Cell Biology, Deutsches Rheuma-Forschungszentrum Berlin,ein Institut der Leibniz Gemeinschaft, Charitéplatz 1, 10117, Berlin, Deutschland,
| | | | | | | |
Collapse
|
34
|
|
35
|
Mundiyanapurath S, Möhlenbruch M, Ringleb PA, Bösel J, Wick W, Bendszus M, Radbruch A. Posterior Circulation Acute Stroke Prognosis Early Computed Tomography Score Using Hypointense Vessels on Susceptibility Weighted Imaging Independently Predicts Outcome in Patients with Basilar Artery Occlusion. PLoS One 2015; 10:e0132587. [PMID: 26176682 PMCID: PMC4503629 DOI: 10.1371/journal.pone.0132587] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2015] [Accepted: 06/16/2015] [Indexed: 01/02/2023] Open
Abstract
PURPOSE Appearance of hypointense vessels on susceptibility weighted imaging (SWI) has been reported to correlate with outcome in patients with ischemia of the anterior circulation. This study investigates the correlation between the appearance of hypointense vessels on SWI after recanalization therapy and outcome in patients with basilar artery occlusion. METHODS Patients with basilar artery occlusion who were treated with endovascular recanalization or intravenous alteplase and received an MRI including SWI after therapy were retrieved from the hospital database for retrospective analysis. Posterior circulation Acute Stroke Prognosis Early Computed Tomography Score (pcASPECTS) was calculated based on regions displaying hypointense vessels on SWI and compared to lesions on diffusion weighted imaging (DWI). Subsequently, SWI based pcASPECTS was correlated with outcome determined with modified Rankin Scale (mRS), categorized as favorable outcome (mRS 0-2) or unfavorable outcome (3-6). RESULTS Twenty-two MRI of patients with basilar artery occlusion were analyzed. In seven out of eight areas of the pcASPECTS hypointense vessels on SWI were significantly correlated to areas of restricted diffusion on DWI. In univariate analysis median pcASPECTS on SWI was significantly higher in patients with favorable outcome (7.5 vs. 5, p=0.02). In a multivariate analysis pcASPECTS on SWI was an independent predictor of favorable outcome (OR 2.02; CI [1.02;3,99]; p=0.04). CONCLUSION pcASPECTS based on hypointense vessels on SWI after therapy predicts outcome in patients with basilar artery occlusion and might potentially be used as an additional imaging biomarker in the management of patients with stroke in the posterior circulation. This needs to be confirmed in larger prospective clinical trials.
Collapse
Affiliation(s)
- S. Mundiyanapurath
- Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany
| | - M. Möhlenbruch
- Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany
| | - P. A. Ringleb
- Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany
| | - J. Bösel
- Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany
| | - W. Wick
- Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany
| | - M. Bendszus
- Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany
| | - A. Radbruch
- Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany
- German Cancer Research Center, Department of Radiology, Heidelberg, Germany
- * E-mail:
| |
Collapse
|
36
|
Latsoudis H, Mashreghi MF, Gruen J, Chang HD, Stuhlmueller B, Repa A, Gergiannaki I, Papakosta P, Kabouraki E, Kardassis D, Haeupl T, Radbruch A, Sidiropoulos P, Boumpas D, Goulielmos G. SAT0531 Altered Expression Levels of MIR-4520A Associated with Familial Mediterranean Fever (FMF). Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.4047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
37
|
Maschmeyer P, Zimmermann J, Tran C, Haftmann C, Rausch B, Riedel R, Herzog S, Chang HD, Radbruch A, Mashreghi MF. AB0038 Modulation of the Survival of Proinflammatory TH1 Lymphocytes by Stable Expression of MIR-148A Sponges in a Murine Model of Transfer Colitis. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.6389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
38
|
|
39
|
Khodadadi L, Cheng Q, Winter O, Taddeo A, Radbruch A, Hoyer BF, Hiepe F. A8.26 Bortezomib ameliorates the disease progression due to ovalbumin immunisation in NZB/W F1 lupus prone mice. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-207259.211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
40
|
Smiljanovic B, Stuhlmüller B, Bonin M, Pade S, Backhaus B, Burmester GR, Radbruch A, Grützkau A, Häupl T. A6.37 The synovial tissue transcriptome reveals combinations of protein biomarkers for unambiguous identification of RA patients from synovial fluid and for quantification of disease activity in serum. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-207259.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
41
|
Serra A, Könnecke I, Khassawna TE, Schlundt C, Schell H, Hauser A, Ellinghaus A, Volk HD, Radbruch A, Duda GN, Schmidt-Bleek K. A4.7 T and B cells participate in bone repair by infiltrating the fracture callus in a two-wave fashion. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-207259.89] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
42
|
Taddeo A, Hoyer BF, Gerl V, Chang HD, Pelz A, Kohler S, Radbruch A, Hiepe F. A8.28 Depletion of autoantibody-secreting plasma cells based on the specificity of the secreted antibody. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-207259.213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
43
|
Hoyer BF, Cheng Q, Taddeo A, Khodadadi L, Wu K, Rudolph B, Radbruch A, Manz RF, Hiepe F. A6.35 Differential B and plasma cell homing mechanisms in inflamed kidneys of NZB/W F1 mice. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-207259.161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
44
|
Radbruch A, Schulze-Koops H. [From cellular pathology to cell therapy]. Z Rheumatol 2015; 74:6-7. [PMID: 25676123 DOI: 10.1007/s00393-014-1436-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- A Radbruch
- Deutsches Rheuma-Forschungszentrum (DRFZ), Charitéplatz 1, 10117, Berlin, Deutschland,
| | | |
Collapse
|
45
|
Kickingereder P, Sahm F, Wiestler B, Roethke M, Heiland S, Schlemmer HP, Wick W, von Deimling A, Bendszus M, Radbruch A. Evaluation of microvascular permeability with dynamic contrast-enhanced MRI for the differentiation of primary CNS lymphoma and glioblastoma: radiologic-pathologic correlation. AJNR Am J Neuroradiol 2014; 35:1503-8. [PMID: 24722313 DOI: 10.3174/ajnr.a3915] [Citation(s) in RCA: 67] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
BACKGROUND AND PURPOSE Dynamic contrast-enhanced MR imaging can provide in vivo assessment of the microvasculature in intracranial tumors. The aim of the present study was to evaluate the diagnostic performance of dynamic contrast-enhanced MR imaging derived vascular permeability parameters, including the volume transfer constant, the volume of extravascular extracellular space, and the flux rate constant between the extravascular extracellular space and plasma, for the differentiation of primary CNS lymphoma and glioblastoma. MATERIALS AND METHODS Sixty glioblastomas and 11 primary central nervous system lymphomas were included. Pretreatment T1-weighted dynamic contrast-enhanced MR imaging with a 3D T1-weighted spoiled gradient-echo sequence was performed on a 3T MR imaging scanner. Perfusion parameters (volume transfer constant, the volume of extravascular extracellular space, and the flux rate constant) were measured on the basis of the Tofts-Kernmode model. The Mann-Whitney U test and receiver operating characteristic analysis were used to compare those parameters between primary central nervous system lymphoma and glioblastoma. Histopathologic correlation of dynamic contrast-enhanced MR imaging findings was performed by using reticulin staining and CD31 immunohistochemistry. RESULTS Median volume transfer constant and flux rate constant values were significantly higher in primary central nervous system lymphoma (0.145 ± 0.057 and 0.396 ± 0.088) than in glioblastoma (0.064 ± 0.021 and 0.230 ± 0.058) (P < .001, respectively). Median volume of extravascular extracellular space values did not differ significantly between primary central nervous system lymphoma (0.434 ± 0.165) and glioblastoma (0.319 ± 0.107). On receiver operating characteristic analysis, volume transfer constant had the best discriminative value for differentiating primary central nervous system lymphoma and glioblastoma (threshold, 0.093; sensitivity, 90.9%; specificity, 95.0%). Histopathologic evaluation revealed intact vascular integrity in glioblastoma despite endothelial proliferation, whereas primary central nervous system lymphoma demonstrated destroyed vessel architecture, thereby promoting vascular disintegrity. CONCLUSIONS Primary central nervous system lymphoma demonstrated significantly higher volume transfer constant and flux rate constant values compared with glioblastoma, implying a higher vascular permeability in primary central nervous system lymphoma. These findings confirm initial observations from perfusion CT and dynamic contrast-enhanced MR imaging studies, correlating with underlying histopathologic features, and may be useful in distinguishing primary central nervous system lymphoma from glioblastoma.
Collapse
Affiliation(s)
- P Kickingereder
- From the Departments of Neuroradiology (P.K., S.H., M.B., A.R.)
| | - F Sahm
- Neuropathology (F.S., A.v.D.)German Cancer Consortium, Clinical Cooperation Unit Neuropathology (F.S., A.v.D.)
| | - B Wiestler
- Neuro-oncology (B.W., W.W.), Neurology Clinic, University of Heidelberg Medical Center, Heidelberg, GermanyClinical Cooperation Unit Neuro-oncology (B.W., W.W.)
| | - M Roethke
- Department of Radiology (M.R., H.-P.S., A.R.), German Cancer Research Center, Heidelberg, Germany
| | - S Heiland
- From the Departments of Neuroradiology (P.K., S.H., M.B., A.R.)
| | - H-P Schlemmer
- Department of Radiology (M.R., H.-P.S., A.R.), German Cancer Research Center, Heidelberg, Germany
| | - W Wick
- Neuro-oncology (B.W., W.W.), Neurology Clinic, University of Heidelberg Medical Center, Heidelberg, GermanyClinical Cooperation Unit Neuro-oncology (B.W., W.W.)
| | - A von Deimling
- Neuropathology (F.S., A.v.D.)German Cancer Consortium, Clinical Cooperation Unit Neuropathology (F.S., A.v.D.)
| | - M Bendszus
- From the Departments of Neuroradiology (P.K., S.H., M.B., A.R.)
| | - A Radbruch
- From the Departments of Neuroradiology (P.K., S.H., M.B., A.R.)Department of Radiology (M.R., H.-P.S., A.R.), German Cancer Research Center, Heidelberg, Germany
| |
Collapse
|
46
|
Alexander T, Sarfert R, Klotsche J, Rubbert-Roth A, Lorenz HM, Rech J, Hoyer B, Cheng Q, Waka A, Taddeo A, Kühl A, Schett G, Burmester GR, Radbruch A, Hiepe F, Voll R. FRI0394 The Proteasome Inhibitor Bortezomib Ameliorates Refractory Systemic Lupus Erythematosus (SLE): A Prospective Multi-Centre Observational Study. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.5884] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
47
|
Mashreghi MF, Latsoudis H, Gruen J, Chang HD, Sidiropoulos P, Radbruch A, Boumpas D, Goulielmos G. THU0467 Silencing of the MEFV Gene in Familial Mediterranean Fever and Transcriptomic Analysis in Human Monocytes: Evidence for the Involvement of Pyrin in Innate Immune Responses and Autophagy. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2470] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
48
|
Taddeo A, Khodadadi L, Cheng Q, Radbruch A, Hiepe F, Hoyer B. THU0041 Autoreactive Long-Lived Plasma Cells in Nzb/W Mice and their Regeneration. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.3408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
49
|
Luger E, Radbruch A. Die Herausforderung: Verständnis der molekularen Pathogenese der Arthrose und Entwicklung innovativer Therapiekonzepte. Z Rheumatol 2014; 73:310-4. [DOI: 10.1007/s00393-014-1390-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
50
|
Radbruch A, Paech D, Windschuh J, Meissner JE, Schlemmer HP, Bachert P, Ladd M, Bendszus M. Three-dimensional Chemical Exchange Saturation Transfer (CEST) Imaging at 7 Tesla in Glioblastoma Patients. ROFO-FORTSCHR RONTG 2014. [DOI: 10.1055/s-0034-1373350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|